이장희 교수
031-8086-2440
학력
2011연세대학교 의과대학 졸업 2018연세대학교 의학대학원 의학 석사 도쿄 National cancer center 연수 |
경력
연세대학교세브란스병원 수련/전공의 수료 해군 청해부대 23진 의무참모 해병 2사단 의무근무대대 외과과장 연세대학교강남세브란스병원 유방외과 임상강사 한림대학교동탄성심병원 유방내분비외과 임상조교수 한림대학교동탄성심병원 유방내분비외과 조교수 |
학회활동
대한외과학회 정회원 유럽종양학회(European Society for Medical Oncology) 정회원 미국 Society of Surgical Oncology (SSO) 정회원 한국유방암학회 정회원 대한종양외과 학회 평생회원 |
수상이력
세브란스 병원 전공의 우수논문상 |
논문/저서
|
국내학회지 발표논문 1. Lee J, Park S, Kim S, et al: Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers. Yonsei Med J 56:1213-20, 2015 2. Lee J, Choi YY, An JY, et al: Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center. Ann Surg Oncol 22:3929-37, 2015 국제학회지 발표논문 1. Ko SM, Lee J, Bae SJ, Baik SJ, Ji J, Kim D, et al. Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients. Br J Cancer 2021;125:119-25. 2. Lee J, Kim JY, Bae SJ, Cho Y, Ji JH, Kim D, et al. The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy. Cancers (Basel) 2021;13. 3. Cha C, Ahn SG, Kim D, Lee J, Park S, Bae SJ, et al. Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer. Int J Cancer 2021;149:1585-92. 4. Bae SJ, Cha YJ, Eun NL, Ji JH, Kim D, Lee J, et al. Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution. Radiology 2021;301:47-56. 5. Bae SJ, Ahn SG, Ji JH, Chu C, Kim D, Lee J, et al. Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk. Cancers (Basel) 2021;13. 6. Park S, Min EK, Bae SJ, Cha C, Kim D, Lee J, et al. Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm. Sci Rep 2021;11:12046. 7. Ahn SG, Bae SJ, Kim Y, Ji JH, Chu C, Kim D, et al. Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR. NPJ Breast Cancer 2022;8:58. |